h1

000164158 001__ 164158
000164158 005__ 20231024094602.0
000164158 0247_ $$2ISSN$$a1476-4598
000164158 0247_ $$2BIOSIS$$aPREV201100748638
000164158 0247_ $$2pmid$$apmid:21999842
000164158 0247_ $$2WOS$$aWOS:000296852000001
000164158 0247_ $$2DOI$$a10.1186/1476-4598-10-129
000164158 0247_ $$2HSB$$aeva15841
000164158 0247_ $$2datacite_doi$$a10.18154/RWTH-CONV-042075
000164158 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-80053973302
000164158 037__ $$aRWTH-CONV-042075
000164158 041__ $$aEnglish
000164158 1001_ $$0P:(DE-82)092054$$aUmmanni, Ramesh$$b0$$eAuthor
000164158 245__ $$aUbiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation$$honline
000164158 260__ $$aLondon$$bBiomed Central$$c2011
000164158 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
000164158 3367_ $$2DataCite$$aOutput Types/Journal article
000164158 3367_ $$00$$2EndNote$$aJournal Article
000164158 3367_ $$2BibTeX$$aARTICLE
000164158 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000164158 3367_ $$2DRIVER$$aarticle
000164158 591__ $$aGermany
000164158 7001_ $$0P:(DE-82)021451$$aJost, Edgar$$b1$$eAuthor$$urwth
000164158 7001_ $$0P:(DE-82)069233$$aBraig, Melanie$$b2$$eAuthor
000164158 7001_ $$0P:(DE-82)092055$$aLohmann, Frithjof$$b3$$eAuthor
000164158 7001_ $$0P:(DE-82)092056$$aMundt, Frederike$$b4$$eAuthor
000164158 7001_ $$0P:(DE-82)092057$$aBarett, Christine$$b5$$eAuthor
000164158 7001_ $$0P:(DE-82)092058$$aSchlomm, Thorsten$$b6$$eAuthor
000164158 7001_ $$0P:(DE-82)071122$$aSauter, Guido$$b7$$eAuthor
000164158 7001_ $$0P:(DE-82)092059$$aSenff, Tina$$b8$$eAuthor$$urwth
000164158 7001_ $$0P:(DE-82)069236$$aBokemeyer, Carsten$$b9$$eAuthor
000164158 7001_ $$0P:(DE-82)092060$$aSültmann, Holger$$b10$$eAuthor
000164158 7001_ $$0P:(DE-82)075857$$aMeyer-Schwesinger, Catherine$$b11$$eAuthor
000164158 7001_ $$0P:(DE-82)IDM06025$$aBrümmendorf, Tim Henrik$$b12$$eAuthor$$urwth
000164158 7001_ $$0P:(DE-82)069240$$aBalabanov, Stefan$$b13$$eCorresponding author
000164158 773__ $$0PERI:(DE-600)2091373-4$$a10.1186/1476-4598-10-129$$p129$$tMolecular cancer$$v10$$x1476-4598
000164158 8564_ $$uhttps://publications.rwth-aachen.de/record/164158/files/164158.pdf$$yOpenAccess
000164158 8564_ $$uhttps://publications.rwth-aachen.de/record/164158/files/164158.gif?subformat=icon$$xicon$$yOpenAccess
000164158 8564_ $$uhttps://publications.rwth-aachen.de/record/164158/files/164158.jpg?subformat=icon-180$$xicon-180$$yOpenAccess
000164158 8564_ $$uhttps://publications.rwth-aachen.de/record/164158/files/164158.jpg?subformat=icon-700$$xicon-700$$yOpenAccess
000164158 8564_ $$uhttps://publications.rwth-aachen.de/record/164158/files/164158.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000164158 909CO $$ooai:publications.rwth-aachen.de:164158$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000164158 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article
000164158 915__ $$0LIC:(DE-HGF)CCBY2$$2HGFVOC$$aCreative Commons Attribution CC BY 2.0
000164158 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000164158 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2$$lLehrstuhl für Innere Medizin (Hämatologie und Onkologie)$$x0
000164158 961__ $$c2014-04-11$$x2012-01-20$$z2012-02-20
000164158 970__ $$aeva15841
000164158 980__ $$ajournal
000164158 980__ $$aI:(DE-82)531040-2_20140620
000164158 980__ $$aVDB
000164158 980__ $$aUNRESTRICTED
000164158 980__ $$aConvertedRecord
000164158 9801_ $$aFullTexts